WJPR Citation New

  All Since 2011
 Citation  2903  2393
 h-index  27  24
 i10-index  68  60

Login

Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
            Best Paper Award :
Dr. Muhammad Baqir MR Fakhrildin
Download Article: Click Here

Search

Track Your Article

Abstract

A STUDY ON STANDARDIZATION OF AKSHI-TARPANA AND TO EVALUATE THE CLINICAL EFFICACY WITH JEEVANTYADI GHRITA IN TIMIRA (MYOPIA)

Dr. Rekha Palawat* and Dr. Manjusha Rajgopala

ABSTRACT

Standardization in Ayurveda practice is the need of the hour and keeping this in mind WHO has framed a code of Drug Manufacturing Practice in Ayurveda.[1] Lack of standardization is considered as the biggest pitfall in the growth and dissemination of Ayurveda. Standardization can be defined as a consistent set of procedures for designing, administering, and scoring an assessment. The purpose of standardization is to ensure that all individuals are assessed under the same conditions and are not influenced by different conditions[2] or Formulation, publication and implementation of guidelines, rules and specifications for common and repeated use, aimed at achieving optimum degree of order or uniformity in a given context, discipline or field.[3] Apart from herbs, minerals and herbomineral compositions, Ayurveda also utilizes certain physio-biological procedures (physical procedures having their instant or remote biological effects) as a measure to eliminate diseases.[4] There are regional variations in the application of these procedures, which have not been addressed properly. Akshi-Tarpana is one such ocular therapeutic procedure which is indicated in many ocular conditions and is widely practiced all over the country. It is highly praised by the Ayurvedic ophthalmic practitioners on account of its sound literary background and on their own clinical experiences. Myopia, commonly referred to as shortsightedness is the most common eye disease in the world with substantial social, educational, and economic impact. Myopia is a refractive error of the eye in which parallel light rays coming from infinity focus in front of retina when accommodation is at rest. Myopia is highly prevalent in our society, affecting at least 25% of the adult population in the United States[5] and is even more common in Asian countries, affecting up to 84% of adolescents. Various surveys in India have found myopia prevalence ranging from 6.9 percent to 19.7 percent.[6] Currently 1.6 billion people suffer from myopia and, globally, 2.5 billion people are projected to be affected within the next 10 years.[7] Remarkable progress has been made in modern ophthalmology branch but no satisfactory treatment for Myopia is available. Myopia is a progressive disease and no cure is available for it. High myopia is a predisposing factor for retinal detachment, myopic retinopathy, and glaucoma, thus contributing to loss of vision and blindness in both developed and developing countries.[8] Refractive surgeries for treatment of myopia are both costly and unsuitable for children‘s eyes and do not change axial elongation, which is the source of most myopia.[9] Hence, the procedures and medications available in Ayurveda can be explored to find some better alternatives which may be effective in these conditions.

Keywords: .


[Full Text Article]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More